Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
It is classified as a triple receptor agonist for its simultaneous activity at the GIP, GLP-1, and glucagon receptors, and is intended strictly for in vitro laboratory research ONLY
They are all GLP-1 receptor agonists, which means they act like the natural GLP-1 hormone in your intestinal tract thats released when you eat
Food Science and Biotechnology
This is especially useful if you are paying out of pocket and without insurance
PT-141 SIDE EFFECTS & RISKS PT-141 went through full FDA Phase 3 clinical trials, so the side effect profile is well-characterized
US$ 26.11
US$ 21.50
US$ 25.00
US$ 21.18
